Sang W. Seo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 477 publications
Longitudinal CDR-Sum of Boxes trajectories in mild cognitive impairment reveal functional heterogeneity beyond cognitive decline: A latent class growth analysis.
Journal: Journal of Alzheimer's disease : JAD
Published: September 03, 2026
Altered T1w/T2w-FLAIR Ratio in White Matter Hyperintensities as an Indicator of Structural Integrity Loss: Association with Alzheimer's Disease and Vascular Dementia.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.
Journal: JAMA
Published: July 13, 2026
Genetically prioritized druggable targets for amyloid-β pathology highlight ACE as a therapeutic candidate in Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: May 29, 2026
APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 13, 2026
Concordance Between [18F]Flortaucipir PET Visual Reads and CenTauR-Based Quantification.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 14, 2026
Epigenetic aging in Alzheimer's disease: Relation to proteome.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 31, 2026
Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum.
Journal: Journal of Alzheimer's disease : JAD
Published: March 26, 2026
Cellular circadian period and its deviation associate with Alzheimer's pathology and brain aging in cognitively impaired older adults.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 02, 2026
Longitudinal plasma p-tau217 as a marker for tracking progression and predicting cognitive decline in Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: January 04, 2026
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use.
Journal: Alzheimer's research & therapy
Published: November 27, 2025
Last Updated: 09/26/2026